Rockland Trust’s Merck MRK Stock Holding History

Rockland Trust’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$63M	Sell	490,049 -44,914	-8%	-$5.26M	2.47%	9
2026 Q1	$64.4M	Sell	534,963 -42,467	-7%	-$4.9M	2.58%	8
2025 Q4	$60.8M	Sell	577,430 -2,909	-0.5%	-$273K	2.39%	8
2025 Q3	$48.7M	Buy	580,339 +30,061	+5%	+$2.48M	2%	10
2025 Q2	$43.6M	Buy	550,278 +57,044	+12%	+$4.53M	2.12%	10
2025 Q1	$44.3M	Buy	493,234 +76,223	+18%	+$7.12M	2.23%	10
2024 Q4	$41.5M	Buy	417,011 +30,562	+8%	+$3.15M	2.11%	11
2024 Q3	$43.9M	Sell	386,449 -14,917	-4%	-$1.77M	2.16%	11
2024 Q2	$49.7M	Sell	401,366 -6,299	-2%	-$811K	2.62%	7
2024 Q1	$53.8M	Sell	407,665 -814	-0.2%	-$100K	2.83%	6
2023 Q4	$44.5M	Buy	408,479 +11,868	+3%	+$1.23M	2.44%	8
2023 Q3	$40.8M	Buy	396,611 +23,808	+6%	+$2.57M	2.46%	8
2023 Q2	$43M	Sell	372,803 -36,018	-9%	-$4.09M	2.57%	8
2023 Q1	$43.5M	Sell	408,821 -1,628	-0.4%	-$176K	2.73%	6
2022 Q4	$45.5M	Sell	410,449 -9,567	-2%	-$978K	2.89%	5
2022 Q3	$36.2M	Buy	420,016 +4,214	+1%	+$376K	2.58%	7
2022 Q2	$37.9M	Buy	415,802 +4,458	+1%	+$395K	2.62%	6
2022 Q1	$33.8M	Buy	411,344 +34,038	+9%	+$2.68M	2.15%	10
2021 Q4	$28.9M	Buy	377,306 +15,836	+4%	+$1.26M	1.84%	13
2021 Q3	$27.1M	Buy	361,470 +76,373	+27%	+$5.81M	1.89%	12
2021 Q2	$22.2M	Buy	285,097 +146,640	+106%	+$10.9M	1.53%	18
2021 Q1	$10.2M	Buy	138,457 +14,133	+11%	+$1.04M	0.73%	48
2020 Q4	$9.7M	Buy	124,324 +13,505	+12%	+$1.03M	0.75%	46
2020 Q3	$8.77M	Sell	110,819 -1,420	-1%	-$111K	0.75%	47
2020 Q2	$8.28M	Sell	112,239 -1,079	-1%	-$81.2K	0.74%	47
2020 Q1	$8.32M	Buy	113,318 +4,070	+4%	+$320K	0.85%	45
2019 Q4	$9.48M	Sell	109,248 -3,422	-3%	-$281K	0.78%	46
2019 Q3	$8.9M	Buy	112,670 +35,605	+46%	+$2.85M	0.81%	45
2019 Q2	$6.17M	Buy	77,065 +1,401	+2%	+$107K	0.61%	57
2019 Q1	$6M	Buy	75,664 +10,033	+15%	+$750K	0.64%	57
2018 Q4	$4.79M	Sell	65,631 -2,145	-3%	-$151K	0.59%	53
2018 Q3	$4.59M	Sell	67,776 -404	-0.6%	-$25.7K	0.56%	53
2018 Q2	$3.95M	Sell	68,180 -585	-0.9%	-$33K	0.51%	57
2018 Q1	$3.57M	Buy	68,765 +2,453	+4%	+$132K	0.47%	59
2017 Q4	$3.56M	Buy	66,312 +2,112	+3%	+$117K	0.46%	61
2017 Q3	$3.92M	Buy	64,200 +2,562	+4%	+$155K	0.59%	50
2017 Q2	$3.77M	Buy	61,638 +2,950	+5%	+$180K	0.59%	51
2017 Q1	$3.56M	Buy	58,688 +184	+0.3%	+$11.2K	0.56%	53
2016 Q4	$3.29M	Sell	58,504 -142	-0.2%	-$8.31K	0.53%	55
2016 Q3	$3.49M	Sell	58,646 -274	-0.5%	-$16K	0.61%	50
2016 Q2	$3.24M	Buy	58,920 +2,170	+4%	+$115K	0.56%	51
2016 Q1	$2.87M	Buy	56,750 +4,590	+9%	+$225K	0.51%	53
2015 Q4	$2.63M	Buy	52,160 +6,014	+13%	+$303K	0.46%	55
2015 Q3	$2.17M	Buy	46,146 +1,581	+4%	+$84K	0.43%	56
2015 Q2	$2.42M	Buy	44,565 +1,009	+2%	+$56.6K	0.48%	47
2015 Q1	$2.39M	Buy	43,556 +1,671	+4%	+$94.6K	0.51%	47
2014 Q4	$2.27M	Buy	41,885 +593	+1%	+$33K	0.47%	48
2014 Q3	$2.34M	Buy	41,292 +5,564	+16%	+$312K	0.51%	44
2014 Q2	$1.97M	Buy	35,728 +17,466	+96%	+$953K	0.45%	45
2014 Q1	$989K	Sell	18,262 -17	-0.1%	-$880	0.23%	58
2013 Q4	$873K	Sell	18,279 -1,445	-7%	-$66.1K	0.21%	69
2013 Q3	$896K	Buy	19,724 +232	+1%	+$10.6K	0.24%	60
2013 Q2	$864K	Buy	+19,492	New	+$871K	0.24%	63

Other funds holding MRK

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Rockland Trust's MRK Position: Q2 2026 in Review

Rockland Trust reduced its Merck (MRK) stake by 8.4% in Q2 2026, selling an estimated $5.26M and leaving 490,049 shares worth $63M. The position accounts for 2.47% of the portfolio, ranked #9.

Rockland Trust first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $64.4M in Q1 2026. 1,055 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Rockland Trust held 490,049 shares of Merck worth $63M as of Q2 2026.
Rockland Trust sold 44,914 Merck shares in Q2 2026, an estimated $5.26M.
Merck made up 2.47% of Rockland Trust's portfolio in Q2 2026, its #9 holding.
Rockland Trust first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
Rockland Trust's Merck position peaked at $64.4M in Q1 2026.
1,055 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Rockland Trust's 13F filing for Q2 2026, filed 8 Jul 2026.